These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 9231037)

  • 21. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
    Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pimobendan on the L-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol.
    Matsui K; Kiyosue T; Wang JC; Dohi K; Arita M
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):105-13. PubMed ID: 10372225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum.
    Levijoki J; Pollesello P; Grossini E; Papp Z
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):827-832. PubMed ID: 35170487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
    Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Br J Pharmacol; 1996 Oct; 119(3):609-15. PubMed ID: 8894186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS; Hettrick DA; Warltier DC
    Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
    Abe Y; Ishisu R; Onishi K; Sekioka K; Narimatsu A; Nakano T
    J Pharmacol Exp Ther; 1996 Feb; 276(2):433-9. PubMed ID: 8632307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
    Nagy L; Pollesello P; Haikala H; Végh Á; Sorsa T; Levijoki J; Szilágyi S; Édes I; Tóth A; Papp Z; Papp JG
    Eur J Pharmacol; 2016 Mar; 775():120-9. PubMed ID: 26872993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer.
    Virág L; Hála O; Marton A; Varró A; Papp JG
    Gen Pharmacol; 1996 Apr; 27(3):551-6. PubMed ID: 8723543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
    Lues I; Beier N; Jonas R; Klockow M; Haeusler G
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
    Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
    J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
    Shahid M; Nicholson CD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
    Musialek P; Rigg L; Terrar DA; Paterson DJ; Casadei B
    J Mol Cell Cardiol; 2000 Oct; 32(10):1831-40. PubMed ID: 11013127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation.
    Bódi A; Szilágyi S; Edes I; Papp Z
    Gen Physiol Biophys; 2003 Sep; 22(3):313-27. PubMed ID: 14986883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.
    Herring N; Paterson DJ
    J Physiol; 2001 Sep; 535(Pt 2):507-18. PubMed ID: 11533140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
    Brunkhorst D; v der Leyen H; Meyer W; Nigbur R; Schmidt-Schumacher C; Scholz H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.